XIX International Workshop on CLL 2021 - Virtual Satellite Symposium

 PDF   1   09/2021

Evolving Role of BTK Inhibitors in R/R CLL – A Rational Approach to Improving Patient Outcomes



Anna Schuh (Chair) Welcome, introductions and objectives
Federico Pea A pharmacologist’s view on the rationale for using different BTK inhibitors for R/R CLL
Wojciech Jurczak Evolving strategies with next generation BTK inhibitors as treatment for R/R CLL patients
Othman Al-Sawaf 2 patient case reports in R/R CLL
Anna Schuh (Moderator) Panel discussion
Anna Schuh Audience Q&A


Rate this resource